Search
Analytica's PeriCoach incontinence device

Adult diaper market to increase by 48% to $2.7b

ASX listed medical device company Analytica have pointed to a recent article on Bloomberg, which is getting global coverage on the growth in the adult diaper market to highlight the need for an effective treatment for urinary incontinence, a condition that can be cured or dramatically reduced using Analytica’s “Peri-Coach” device.

The “Peri-Coach” is a medical device that accurately monitors the effectiveness of pelvic floor exercises designed to cure or reduce urinary incontinence.

Urinary incontinence is caused by weakness to the pelvic floor muscles and is most commonly caused by trauma to the muscles during childbirth, but also exercises such as weights training.

For some time, women have used incontinence pads to address the condition and it appears this is on the increase. The Bloomberg article notes that sales of adult incontinence garments in the US could equal those of baby diapers in a decade, with pharmaceutical giants like Kimberly Clark targeting this lucrative adult segment of the market.

Bloomberg states that: “Growth in the adult-diaper market is outpacing that of every other paper-based household staple in the U.S” with Euromonitor International forecasting “a 48 percent increase in sales in the category to $2.7 billion in 2020 from $1.8 billion last year”.

Whilst diapers and pads are an increasingly popular option for women with urinary incontinence, they only address the symptoms and not the underlying cause of the condition. This condition is also linked to many quality of life issues and health conditions like depression, decreases in sexual satisfaction, obesity and diabetes. 

Some PeriCoach customers have reported noticeable improvement in their continence in as little as two weeks, and have stopped using pads in as quickly as two months.

PeriCoach is the only device that monitors pelvic floor muscle strength directly and captures and shares valuable data with patients and clinicians to monitor progress.  The PeriCoach system has FDA clearance in the US, TGA clearance in Australia and CE Marking for Europe.

Analytica’s studies and post-marketing surveys report women who use PeriCoach have reduced or eliminated urinary incontinence symptoms, feel dryer, more secure, more confident and experience the benefits of a stronger pelvic floor in various areas of their lives including sexual function.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 30/06/16

1 year TSR5 year TSR
117thNorthern Star Resources128%65%
158thFortescue Metals Group87%-9%
474thIluka Resources-12%-15%
480thSouth32-14%0%
495thWoodside Petroleum-18%-3%
755 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

18/04/16
$0 Other
18/04/16
$0 Other
14/12/15
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

1st-Fortescue Metals Group$11,264.3m
2nd↑Woodside Petroleum$6,935.4m
3rd-South32$6,492.2m
4th↑Iluka Resources$884.1m
5th↑Northern Star Resources$846.5m
528 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Fortescue Metals Group

3rdNev Power$5.992m
14thStephen Pearce$2.551m
27thNick Cernotta$1.566m
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer